Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank75
3Y CAGR+167.1%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+167.1%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
19.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$10.76M-29.9%
2024$15.36M+573.0%
2023$2.28M+303.9%
2022$565000.00+56400.0%
2021$1000.00-